The global microfluidics market is estimated to be valued at US$22.3 billion in 2023 and is expected to exhibit a CAGR of 13.0% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Microfluidics is a rapidly growing field that involves manipulating and controlling small amounts of fluid in microchannels. The market offers various products such as microfluidic chips, microfluidic devices, and microfluidic pumps. These products have numerous advantages including high accuracy, reduced sample size and reagent consumption, and faster analysis and results. The increasing need for point-of-care testing is driving the growth of the microfluidics market, as it enables faster and more convenient diagnosis and monitoring of diseases.
Market Key Trends:
One key trend in the microfluidics market is the integration of microfluidics with other technologies such as genomics, proteomics, and cell biology. This integration allows for more advanced and efficient analysis of biological samples, leading to improved diagnostics and drug discovery. For example, microfluidic devices combined with genomics technologies enable the rapid and affordable sequencing of DNA, which has revolutionized the field of genomics. This trend is expected to continue driving the growth of the microfluidics market in the coming years.
Threat of New Entrants: The microfluidics market faces a moderate threat of new entrants. Although the market offers high growth potential, the presence of well-established key players and the requirement of substantial investment in research and development may act as barriers to entry for new players.
Bargaining Power of Buyers: The bargaining power of buyers in the microfluidics market is moderate. While buyers have some flexibility in choosing suppliers, the specialized nature of microfluidic products limits their options. Additionally, the high demand and low supply of microfluidic devices give suppliers some leverage in negotiations.
Bargaining Power of Suppliers: The bargaining power of suppliers in the microfluidics market is relatively high. The market is characterized by a limited number of key players, resulting in a concentration of suppliers. This concentration gives suppliers more control over pricing and terms.
Threat of New Substitutes: The threat of new substitutes in the microfluidics market is low. The unique capabilities of microfluidic technology, such as precise control of fluids in small volumes, make it difficult to find suitable substitutes. Moreover, the continuous advancements in microfluidics research and development further mitigate the threat of substitutes.
Competitive Rivalry: The competitive rivalry in the microfluidics market is high. Key players in the market constantly strive to gain a competitive edge through technological advancements, product innovation, and strategic collaborations. This intense competition enhances product quality and drives market growth.
The global microfluidics market is expected to witness high growth, exhibiting a CAGR of 13.0% over the forecast period (2023-2030). This growth can be attributed to several factors, including increasing research and development activities in the healthcare and pharmaceutical industries, growing demand for point-of-care diagnostics, and advancements in microfluidic technologies.
From a regional analysis perspective, North America is projected to be the fastest-growing and dominating region in the microfluidics market. The region’s growth can be attributed to factors such as the presence of well-established key players, significant investments in research and development, and a strong healthcare infrastructure.
Key players operating in the microfluidics market are Agilent Technologies, PerkinElmer Inc., Thermo Fisher Scientific Inc., Qiagen NV, Bio-Rad Laboratories, Inc., Fluidigm Corporation, Abbott Laboratories, and F. Hoffmann-La Roche Ltd. These key players have a strong market presence and actively engage in strategies such as mergers and acquisitions, partnerships, and product launches to maintain their competitive position in the market.
In conclusion, the microfluidics market is poised for significant growth driven by factors such as increasing R&D activities, growing demand for point-of-care diagnostics, and technological advancements. North America is expected to be the dominant region, and key players will play a crucial role in shaping the market’s competitive landscape.
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it